New Delhi: In the meeting, the Prime Minister is expected to discuss the detailed plans to roll Covid vaccines in all the states, following the Drug Controller General India’s (DCGI) approval for the restricted emergency use of two vaccines Serum Institute’s Covishield and Bharat Biotech’s Covaxin.
The information comes on a day when Union Health Minister Harsh Vardhan announced that the government is in the process of ensuring vaccination for all and the drive will start soon.
On January 3, two intramuscular vaccines – Bharat Biotech’s Covaxin and Oxford-AstraZeneca’s Covishield manufactured by Serum Institute of India – were approved for restricted emergency use. Both are two-dose vaccines.
Covishield is over 70 per cent effective, while Covaxin is currently in the Phase 3 trials but is “safe and provides a robust immune response”, the drug regulator had said last week.
